MMS
Get informed when a big investor buys or sells
+ FollowUndervalued by 139.6% based on the discounted cash flow analysis.
| Market cap | $2.93 Billion |
|---|---|
| Enterprise Value | $2.87 Billion |
| Dividend Yield | $1.26 (2.26%) |
| Earnings per Share | $5.56 |
| Beta | 0.58 |
| Outstanding Shares | 54,547,000 |
| P/E Ratio | 8.15 |
|---|---|
| PEG | 526.5 |
| Price to Sales | 0.58 |
| Price to Book Ratio | 1.8 |
| Enterprise Value to Revenue | 0.54 |
| Enterprise Value to EBIT | 4.83 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.06 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 1539.13% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | 34,500▼ 83.76% |
Holdings and activity of institutional investors.
| Ownership % | 100.99%▼ 4.36% |
|---|---|
| Total Invested | $3.55B▼ 28.80% |
| Investors Holding | 373▼ 14.00% |
No data
Since 1975, Maximus has operated under its founding mission of Helping Government Serve the People®, enabling citizens around the globe to successfully engage with their governments at all levels and across a variety of health and human ...